Melanocortins for Both Male AND Female Sexual Dysfunction: PT-141 and Beyond

Melanocortin agonists (PT-141/bremelanotide, melanotan II) show efficacy for both male erectile dysfunction and female sexual arousal disorder through central MC3R/MC4R activation — the only drug class addressing desire in both sexes.

Shadiack, Annette M et al.·Current topics in medicinal chemistry·2007·Moderate EvidenceReview
RPEP-01288ReviewModerate Evidence2007RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

Melanocortin agonists (bremelanotide, melanotan II) treat sexual dysfunction in both sexes through central MC3R/MC4R activation: ED in men and HSDD/FSAD in women — the only drug class targeting desire/arousal centrally for both genders.

Key Numbers

How They Did This

review study.

Why This Research Matters

Relevant for pt-141, melanotan, sexual-health.

The Bigger Picture

Advances peptide research.

What This Study Doesn't Tell Us

See abstract.

Questions This Raises

  • ?Further research needed.
  • ?Clinical translation to evaluate.

Trust & Context

Key Stat:
Key finding Melanocortin agonists (bremelanotide, melanotan II) treat sexual dysfunction in both sexes through central MC3R/MC4R activation: ED in men and HSDD/FS
Evidence Grade:
moderate evidence.
Study Age:
Published in 2007.
Original Title:
Melanocortins in the treatment of male and female sexual dysfunction.
Published In:
Current topics in medicinal chemistry, 7(11), 1137-44 (2007)
Database ID:
RPEP-01288

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

What was studied?

Melanocortins for Both Male AND Female Sexual Dysfunction: PT-141 and Beyond

What was found?

Melanocortin agonists (PT-141/bremelanotide, melanotan II) show efficacy for both male erectile dysfunction and female sexual arousal disorder through central MC3R/MC4R activation — the only drug class addressing desire in both sexes.

Read More on RethinkPeptides

Cite This Study

RPEP-01288·https://rethinkpeptides.com/research/RPEP-01288

APA

Shadiack, Annette M; Sharma, Shubh D; Earle, Dennis C; Spana, Carl; Hallam, Trevor J. (2007). Melanocortins in the treatment of male and female sexual dysfunction.. Current topics in medicinal chemistry, 7(11), 1137-44.

MLA

Shadiack, Annette M, et al. "Melanocortins in the treatment of male and female sexual dysfunction.." Current topics in medicinal chemistry, 2007.

RethinkPeptides

RethinkPeptides Research Database. "Melanocortins in the treatment of male and female sexual dys..." RPEP-01288. Retrieved from https://rethinkpeptides.com/research/shadiack-2007-melanocortins-in-the-treatment

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.